Vertex Pharma forecasts 2026 revenue in-line, expects growth in cystic fibrosis treatments
VertexVertex(US:VRTX) Reuters·2026-02-12 21:06

Vertex Pharmaceuticals forecast 2026 revenue largely in line with analysts estimates on Thursday, as the drugmaker bets on growth for its cystic fibrosis treatments as well as contributions from newer... ...

Vertex Pharma forecasts 2026 revenue in-line, expects growth in cystic fibrosis treatments - Reportify